Current trends in initial management of oropharyngeal cancer

The declining use of open surgery

Missak Haigentz, Carl E. Silver, June Corry, Eric M. Genden, Robert P. Takes, Alessandra Rinaldo, Alfio Ferlito

Research output: Contribution to journalReview article

57 Citations (Scopus)

Abstract

The widespread availability of novel primary treatment approaches against oropharyngeal cancers has provided several potentially curative surgical and nonsurgical treatment options for patients, generating both hope and controversy. As treatment is usually curative in intent, management considerations must include consideration of primary tumor and nodal disease control as well as long-term toxicities and functional outcomes. Anatomical and functional organ preservation (speech and deglutition) remains of paramount importance to patients with oropharyngeal cancer and the physicians involved in their care, accounting for the growing popularity of chemoradiotherapy and transoral surgical techniques for this indication. These novel approaches have greatly diminished the role of open surgery as initial therapy for oropharyngeal cancers. Open surgery which is often reserved for salvage on relapse, may still be an appropriate therapy for certain early stage primary lesions. The growing treatment armamentarium requires careful consideration for optimal individualized care. The identification of oncogenic human papillomavirus as a predictive and prognostic marker in patients with oropharyngeal cancer has great potential to further optimize the choice of treatment. In this review, novel primary therapies against oropharyngeal squamous cell carcinoma are presented in the context of anatomical, quality of life, and emerging biological considerations.

Original languageEnglish (US)
Pages (from-to)1845-1855
Number of pages11
JournalEuropean Archives of Oto-Rhino-Laryngology
Volume266
Issue number12
DOIs
StatePublished - Dec 1 2009
Externally publishedYes

Fingerprint

Oropharyngeal Neoplasms
Therapeutics
Hope
Organ Preservation
Forensic Anthropology
Chemoradiotherapy
Deglutition
Squamous Cell Carcinoma
Quality of Life
Physicians
Recurrence

All Science Journal Classification (ASJC) codes

  • Otorhinolaryngology

Cite this

Haigentz, Missak ; Silver, Carl E. ; Corry, June ; Genden, Eric M. ; Takes, Robert P. ; Rinaldo, Alessandra ; Ferlito, Alfio. / Current trends in initial management of oropharyngeal cancer : The declining use of open surgery. In: European Archives of Oto-Rhino-Laryngology. 2009 ; Vol. 266, No. 12. pp. 1845-1855.
@article{a70975e68cf1451c930ec2b579c65ef9,
title = "Current trends in initial management of oropharyngeal cancer: The declining use of open surgery",
abstract = "The widespread availability of novel primary treatment approaches against oropharyngeal cancers has provided several potentially curative surgical and nonsurgical treatment options for patients, generating both hope and controversy. As treatment is usually curative in intent, management considerations must include consideration of primary tumor and nodal disease control as well as long-term toxicities and functional outcomes. Anatomical and functional organ preservation (speech and deglutition) remains of paramount importance to patients with oropharyngeal cancer and the physicians involved in their care, accounting for the growing popularity of chemoradiotherapy and transoral surgical techniques for this indication. These novel approaches have greatly diminished the role of open surgery as initial therapy for oropharyngeal cancers. Open surgery which is often reserved for salvage on relapse, may still be an appropriate therapy for certain early stage primary lesions. The growing treatment armamentarium requires careful consideration for optimal individualized care. The identification of oncogenic human papillomavirus as a predictive and prognostic marker in patients with oropharyngeal cancer has great potential to further optimize the choice of treatment. In this review, novel primary therapies against oropharyngeal squamous cell carcinoma are presented in the context of anatomical, quality of life, and emerging biological considerations.",
author = "Missak Haigentz and Silver, {Carl E.} and June Corry and Genden, {Eric M.} and Takes, {Robert P.} and Alessandra Rinaldo and Alfio Ferlito",
year = "2009",
month = "12",
day = "1",
doi = "10.1007/s00405-009-1109-2",
language = "English (US)",
volume = "266",
pages = "1845--1855",
journal = "Archiv fur klinische und experimentelle Ohren- Nasen- und Kehlkopfheilkunde",
issn = "0003-9195",
publisher = "Springer Verlag",
number = "12",

}

Current trends in initial management of oropharyngeal cancer : The declining use of open surgery. / Haigentz, Missak; Silver, Carl E.; Corry, June; Genden, Eric M.; Takes, Robert P.; Rinaldo, Alessandra; Ferlito, Alfio.

In: European Archives of Oto-Rhino-Laryngology, Vol. 266, No. 12, 01.12.2009, p. 1845-1855.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Current trends in initial management of oropharyngeal cancer

T2 - The declining use of open surgery

AU - Haigentz, Missak

AU - Silver, Carl E.

AU - Corry, June

AU - Genden, Eric M.

AU - Takes, Robert P.

AU - Rinaldo, Alessandra

AU - Ferlito, Alfio

PY - 2009/12/1

Y1 - 2009/12/1

N2 - The widespread availability of novel primary treatment approaches against oropharyngeal cancers has provided several potentially curative surgical and nonsurgical treatment options for patients, generating both hope and controversy. As treatment is usually curative in intent, management considerations must include consideration of primary tumor and nodal disease control as well as long-term toxicities and functional outcomes. Anatomical and functional organ preservation (speech and deglutition) remains of paramount importance to patients with oropharyngeal cancer and the physicians involved in their care, accounting for the growing popularity of chemoradiotherapy and transoral surgical techniques for this indication. These novel approaches have greatly diminished the role of open surgery as initial therapy for oropharyngeal cancers. Open surgery which is often reserved for salvage on relapse, may still be an appropriate therapy for certain early stage primary lesions. The growing treatment armamentarium requires careful consideration for optimal individualized care. The identification of oncogenic human papillomavirus as a predictive and prognostic marker in patients with oropharyngeal cancer has great potential to further optimize the choice of treatment. In this review, novel primary therapies against oropharyngeal squamous cell carcinoma are presented in the context of anatomical, quality of life, and emerging biological considerations.

AB - The widespread availability of novel primary treatment approaches against oropharyngeal cancers has provided several potentially curative surgical and nonsurgical treatment options for patients, generating both hope and controversy. As treatment is usually curative in intent, management considerations must include consideration of primary tumor and nodal disease control as well as long-term toxicities and functional outcomes. Anatomical and functional organ preservation (speech and deglutition) remains of paramount importance to patients with oropharyngeal cancer and the physicians involved in their care, accounting for the growing popularity of chemoradiotherapy and transoral surgical techniques for this indication. These novel approaches have greatly diminished the role of open surgery as initial therapy for oropharyngeal cancers. Open surgery which is often reserved for salvage on relapse, may still be an appropriate therapy for certain early stage primary lesions. The growing treatment armamentarium requires careful consideration for optimal individualized care. The identification of oncogenic human papillomavirus as a predictive and prognostic marker in patients with oropharyngeal cancer has great potential to further optimize the choice of treatment. In this review, novel primary therapies against oropharyngeal squamous cell carcinoma are presented in the context of anatomical, quality of life, and emerging biological considerations.

UR - http://www.scopus.com/inward/record.url?scp=70350569994&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70350569994&partnerID=8YFLogxK

U2 - 10.1007/s00405-009-1109-2

DO - 10.1007/s00405-009-1109-2

M3 - Review article

VL - 266

SP - 1845

EP - 1855

JO - Archiv fur klinische und experimentelle Ohren- Nasen- und Kehlkopfheilkunde

JF - Archiv fur klinische und experimentelle Ohren- Nasen- und Kehlkopfheilkunde

SN - 0003-9195

IS - 12

ER -